home / stock / bpts / bpts news


BPTS News and Press, Biophytis SA From 03/30/23

Stock Information

Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ

Menu

BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...

BPTS - SCYNEXIS, Palisade top healthcare gainers; AngioDynamics, Avidity lead losers' pack

2023-03-30 10:02:34 ET Gainers: SCYNEXIS ( SCYX ) +61% . Palisade Bio ( PALI ) +33% . Biophytis ( BPTS ) +10% . RenovoRx ( RNXT ) +9% . VYNE Therapeutics ( VYNE ) +9% . Losers: AngioDynamics ( ANGO ) -28% . ...

BPTS - Biophytis: Biophytis Presented Sarconeos (BIO101) As A Possible Treatment Candidate for Long COVID After Hospitalization During The 13th Annual International Conference on Frailty and Sarcopenia Resea

Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Research (ICFSR) PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / March 27, 2023 / Biophytis SA (NasdaqCM:BPTS)(...

BPTS - Biophytis Announces Ratio Change Under its American Depositary Receipt ("ADR") Program

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / March 17, 2023 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, in...

BPTS - Why Is SVB Financial (SIVB) Stock Down 38% Today?

2023-03-09 09:35:33 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips SVB Financial (NASDAQ: SIVB ) stock is falling on Thursday after the company announced a proposed public stock offering . According to a press release, SVB Financial int...

BPTS - Why Is Silvergate Capital (SI) Stock Down 38% Today?

2023-03-09 09:09:02 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Silvergate Capital (NYSE: SI ) stock is falling hard on Thursday after the crypto bank revealed liquidation plans . According to a press release from the company, it int...

BPTS - Why Is Biophytis (BPTS) Stock Up 28% Today?

2023-03-09 08:42:30 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biophytis (NASDAQ: BPTS ) stock took off on Thursday after the company revealed results from a recent clinical trial . The big news affecting BPTS stock today comes from...

BPTS - Biophytis To Present Positive Results of Phase 2-3 COVA Study At ERS 2023 21st Lung Science Conference

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 9, 2023 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging, inc...

BPTS - 5 Penny Stocks To Watch With Big News This Week

Penny Stocks To Watch Building a penny stocks watch list is easier than you think. You don’t necessarily need to know a company’s financial history or its management’s business acumen. When trading penny stocks , the usual action taken is trading them. Even though the...

BPTS - Biophytis Announces the Signature of a Master Service Agreement With Intsel Chimos, a Pharmaceutical Company That Will Operate Sarconeos (BIO101) in France for the Treatment of Severe Forms of COVID-19

Biophytis and Intsel Chimos signed a master service agreement under which Intsel Chimos will be the operating pharmaceutical company/exploitant, partner and distributor in France for the drug Sarconeos (BIO101) developed by Biophytis in the context of the early access program application. Th...

BPTS - Biophytis Initiates the Regulatory Process for an Early Access Authorization in France from the French National Authority for Health (HAS) for the Treatment with Sarconeos (BIO101) of Severe Forms of COVID-19

Biophytis to present the early access application in France at a pre-filing meeting in March with the HAS Biophytis plans to file the application shortly after with the objective of obtaining early access authorization in France in the second quarter of 2023 Biophytis is pursuing in par...

Previous 10 Next 10